Rein Therapeutics Cash Flow Statement (2016-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-7.24M	-76.51M	-8.56M	-8.17M	-6.58M	-82.09M	-4.98M	-1.99M	-1.98M	-25.80M	-16.10M	-11.30M	-9.45M	-73.24M	-6.57M	-7.31M	-5.64M	-32.80M	-5.55M	-6.55M
Depreciation and Depletion (Quarter)	0.01M	0.11M	0.01M	0.01M	0.01M	0.12M	0.01M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.66M	0.61M	0.69M	0.53M	0.44M	0.42M	0.39M	0.30M	0.23M	0.27M	0.53M	0.33M	0.51M	0.13M	0.26M	1.87M	1.45M	0.26M	0.16M	1.56M
Cash from Operations (Quarter)	-7.26M	-6.25M	-7.80M	-5.68M	-6.97M	-4.41M	-4.66M	-3.12M	-1.64M	-10.39M	-5.27M	-8.39M	-3.82M	-4.81M	-6.17M	-6.42M	-3.55M	-3.22M	-3.42M	-8.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.07M	-0.03M	0.00M	0.02M	0.06M	0.12M	0.10M	0.05M	0.00M	-0.19M									0.62M	0.45M
Depreciation & Amortization (CF) (Quarter)	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.01M	0.01M	0.05M	0.06M	0.00M				0.00M
Change in Working Capital
Change in Account Payables (Quarter)	0.02M	0.18M	-0.19M	0.72M	-0.80M	0.78M	-1.26M	-0.32M	0.35M	-3.75M	0.97M	-1.37M	0.30M	-0.17M	0.24M	4.88M	-1.91M	-0.15M	2.29M	-1.89M
Change in Accured Expenses (Quarter)	0.27M	-0.23M	-0.21M	0.32M	0.21M	-1.89M	0.80M	-1.36M	0.08M	0.11M	-0.77M	1.78M	0.43M	0.26M	-0.01M	-3.16M	-0.03M	0.58M	0.25M	-0.91M
Other Working Capital Changes (Quarter)													-0.12M	0.28M	-0.28M
Investing Activities
Capital Expenditures (Quarter)	0.01M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	23.75M	5.00M	16.36M	13.25M	12.00M	6.70M	7.25M	8.50M	0.50M
Cash from Investing Activities (Quarter)	4.09M	2.25M	11.65M	5.86M	4.18M	4.76M	7.25M	8.50M	0.54M	-0.10M
Financing Activities
Other financing activities (Quarter)	0.03M	0.00M										0.10M	-0.10M	7.03M	0.00M	1.59M	-1.59M	1.59M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)																			4.30M	1.07M
Change in Capital Stock
Shares Issued (Quarter)	9.14M	0.47M		11.12M	5.34M	0.29M	0.32M	0.49M	0.47M	1.88M	1.88M	2.20M	2.19M	3.12M	2.04M	3.07M	2.05M	3.12M	2.47M	3.55M
Net Equity Issued and Repurchased (Quarter)												10.94M	-0.29M		0.74M	-0.37M		1.45M	0.35M	53.19M
Misc.
Cash from Financing Activities (Quarter)	0.03M	0.00M								15.79M		18.26M	-0.45M	0.00M	0.74M	4.71M	1.90M	2.40M	4.65M	47.81M
Exchange Rate Effect (Quarter)										-0.06M				-0.00M			-0.03M	-0.02M
Change in Cash (Quarter)	-3.15M	-4.00M	3.85M	0.18M	-2.79M	0.35M	2.59M	5.38M	-1.10M	5.24M	-5.27M	9.88M	-4.26M	-4.81M	-5.44M	-1.71M	-1.67M	-0.83M	1.23M	4.10M
Free Cash Flow (Quarter)	-7.26M	-6.25M	-7.80M	-5.68M	-6.97M	-4.41M	-4.66M	-3.12M	-1.64M	-10.39M	-5.27M	-8.39M	-3.82M	-4.81M	-6.17M	-6.42M	-3.55M	-3.22M	-3.42M	-8.64M
Net Cash Flow (Quarter)	-3.15M	-4.00M	3.85M	0.18M	-2.79M	0.35M	2.59M	5.38M	-1.10M	5.31M	-5.27M	9.87M	-4.26M	-4.81M	-5.44M	-1.71M	-1.65M	-0.81M	1.23M	39.17M

Research Tools

Datasets

Plans

Developers

Rein Therapeutics RNTX Cash Flow Statement (2016-2026)

Research Tools

Datasets

Plans

Developers

Rein Therapeutics RNTX Cash Flow Statement (2016-2026)

Create an account

Sign In

Reset Password